ConfirmMDx Assay in Multiparametric MRI (mpMRI) PIRADS Scored Lesions After a Negative MR/US Fusion Biopsy
NCT03597386 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2019-03-01
Summary
The purpose of this study is to see if the ConfirmMDx assay is useful in finding prostate cancer in patients who are at increased risk for prostate cancer based on elevated PSA and prostate lesion identified on mpMRI.
Conditions
- Prostate Disease
Sponsors & Collaborators
-
University of Rochester
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-23
- Primary Completion
- 2019-01-24
- Completion
- 2019-01-24
Countries
- United States
Study Locations
More Related Trials
-
A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy Approaches
NCT03632655 ·Status: TERMINATED ·Phase: NA
-
Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy
NCT02488096 ·Status: COMPLETED ·Phase: NA
-
Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology
NCT05046782 ·Status: WITHDRAWN ·Phase: PHASE2
-
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer
NCT04599218 ·Status: RECRUITING ·Phase: NA
-
Sequential bpMRI for Suspicious Prostate Lesions
NCT07332832 ·Status: NOT_YET_RECRUITING
-
Comparison of Multi-parametric and Bi-parametric Magnetic Resonance Imaging in Men With Suspicion of Prostate Cancer
NCT03693703 ·Status: COMPLETED ·Phase: NA
-
PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy
NCT06923657 ·Status: RECRUITING ·Phase: NA
-
MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy
NCT00775866 ·Status: COMPLETED ·Phase: NA
-
MRI Versus PSA in Prostate Cancer Screening
NCT02799303 ·Status: UNKNOWN ·Phase: NA
-
MRI Before Biopsy in Diagnosing Patients With Prostate Cancer
NCT02131207 ·Status: TERMINATED
-
MRI Guided Prostate Biopsy
NCT06302595 ·Status: RECRUITING ·Phase: NA
-
Evaluation of MRI for Prostate Cancer
NCT00930748 ·Status: TERMINATED
-
Predicting Prostate Biopsy Results With Biomarkers and mpMRI.
NCT03730324 ·Status: COMPLETED ·Phase: NA
-
Micro-ultrasound for Prostate Cancer Diagnosis
NCT04832997 ·Status: TERMINATED ·Phase: NA
-
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
NCT06865768 ·Status: RECRUITING ·Phase: PHASE2
-
Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer
NCT03697148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Advanced Magnetic Resonance Imaging (MRI) in Men With Suspected Prostate Cancer
NCT02745496 ·Status: COMPLETED ·Phase: NA
-
Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy
NCT03044197 ·Status: COMPLETED ·Phase: NA
-
MRI Guided Prostate Cancer Focal Laser Ablation
NCT03634579 ·Status: TERMINATED ·Phase: NA
-
Functional MRI Use in Prostate Radiation Treatment Planning
NCT01985932 ·Status: COMPLETED ·Phase: NA
-
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma
NCT00230386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy
NCT01913197 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
MR/TRUS Fusion Guided Prostate Biopsy
NCT04026763 ·Status: UNKNOWN ·Phase: NA
-
Prostate Biopsies With Target Lesion on MRI
NCT04692207 ·Status: COMPLETED
-
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
NCT03149861 ·Status: COMPLETED ·Phase: NA